Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Recommendation of “Buy” by Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) has received an average rating of “Buy” from the sixteen analysts that are currently covering the firm, MarketBeat.com reports. Eleven research analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have covered the stock in the last year is $39.19.

A number of research analysts recently weighed in on PRVA shares. The Goldman Sachs Group assumed coverage on shares of Privia Health Group in a research report on Friday, February 3rd. They set a “buy” rating and a $32.00 price objective on the stock. Credit Suisse Group reaffirmed an “outperform” rating and issued a $41.00 price objective on shares of Privia Health Group in a research note on Tuesday, March 7th. SVB Securities lifted their price objective on shares of Privia Health Group from $39.00 to $40.00 in a research report on Friday, May 5th. Stephens began coverage on shares of Privia Health Group in a research note on Tuesday, April 11th. They issued an “overweight” rating and a $33.00 price target on the stock. Finally, Royal Bank of Canada assumed coverage on shares of Privia Health Group in a research note on Thursday, March 9th. They set an “outperform” rating and a $36.00 price target on the stock.

Privia Health Group Price Performance

PRVA stock opened at $25.24 on Friday. The company has a market cap of $2.92 billion, a P/E ratio of 229.45, a PEG ratio of 3.17 and a beta of 0.77. The firm has a 50-day moving average of $26.98 and a 200 day moving average of $26.06. Privia Health Group has a 1 year low of $20.64 and a 1 year high of $44.64.

Privia Health Group (NASDAQ:PRVA – Get Rating) last posted its quarterly earnings results on Tuesday, February 28th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.17. The firm had revenue of $364.42 million for the quarter, compared to analysts’ expectations of $337.16 million. Privia Health Group had a net margin of 1.14% and a return on equity of 3.20%. On average, equities research analysts expect that Privia Health Group will post 0.23 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, major shareholder Advisors L.L.C. Mbd sold 24,819,473 shares of the business’s stock in a transaction that occurred on Monday, May 8th. The stock was sold at an average price of $21.61, for a total transaction of $536,348,811.53. Following the transaction, the insider now directly owns 110,337 shares in the company, valued at approximately $2,384,382.57. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Privia Health Group news, Director William M. Sullivan sold 18,153 shares of Privia Health Group stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $26.54, for a total transaction of $481,780.62. Following the completion of the sale, the director now directly owns 5,673,861 shares of the company’s stock, valued at approximately $150,584,270.94. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Advisors L.L.C. Mbd sold 24,819,473 shares of the stock in a transaction on Monday, May 8th. The shares were sold at an average price of $21.61, for a total transaction of $536,348,811.53. Following the completion of the transaction, the insider now directly owns 110,337 shares in the company, valued at $2,384,382.57. The disclosure for this sale can be found here. Over the last three months, insiders have sold 25,371,773 shares of company stock valued at $551,840,171. Corporate insiders own 44.80% of the company’s stock.

Institutional Trading of Privia Health Group

Several large investors have recently bought and sold shares of PRVA. Signaturefd LLC purchased a new position in shares of Privia Health Group in the 3rd quarter worth $32,000. HighMark Wealth Management LLC boosted its position in Privia Health Group by 46.1% during the 1st quarter. HighMark Wealth Management LLC now owns 1,315 shares of the company’s stock worth $36,000 after acquiring an additional 415 shares during the period. Assetmark Inc. increased its stake in Privia Health Group by 35.2% during the 3rd quarter. Assetmark Inc. now owns 1,207 shares of the company’s stock valued at $41,000 after buying an additional 314 shares during the period. Focused Wealth Management Inc acquired a new stake in Privia Health Group in the fourth quarter worth approximately $41,000. Finally, James Investment Research Inc. acquired a new position in Privia Health Group during the first quarter worth about $44,000. Institutional investors and hedge funds own 66.83% of the company’s stock.

About Privia Health Group

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.